Howard E. Greene Jr., Director at AMYLIN PHARMACEUTICALS INC (AMLN), sold 3,700 shares at $28.74 ($106K) on 2008-02-19, disclosed to the SEC on 2008-02-20.
Scheduled sale ($106k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TNDM | SELL | 2018-11-07 | $861K | — | Filing → |
| TNDM | BUY | 2018-02-13 | $100K | — | Filing → |
| TNDM | SELL | 2015-08-04 | $254K | — | Filing → |